About us

Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and debilitating conditions like Coagulation and Neurological Disorders, and Primary and Secondary Immunodeficiencies.

In Poland Kedrion Biopharma GmbH (spółka z ograniczoną odpowiedzialnością) Oddział w Polsce is specialized in marketing, sales and distribution of plasma-derivatives.

Read more


As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

Below the list of Kedrion products distributed in Poland (updated March 2022).



Contact us

Thank you for your interest in Kedrion. You can contact us by submitting a message form. Please follow the links below according to your interests or subject of inquiry.

For commercial information

EN: Kedrion In The World
Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact the Medical Information Request Form below to learn more.

EN: Medical scientific information
Qualification *
If medical, please indicate your specialty
If patient, please report the contact details of the doctor or the treating center
Please do not use this field to report adverse events (side effects) or product complaints: In the event of a complaint, please contact the Quality Assurance department. In case of adverse reactions please contact the Pharmacovigilance.
Privacy Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

How to, and to whom, report an adverse reaction
Contact the Competent Authority’s Pharmacovigilance Office.

If you wish to directly notify Kedrion about a suspected adverse reaction related to our drugs, please fill in the form below:

EN: Pharmacovigilance
Qualification *
Gender (M/F)
Has the adverse event stopped?
How bad was the adverse event?
How is the adverse event now?
In processing your personal data, Kedrion will fully comply with internationally recognized standards of data protection. In doing so, Kedrion ensures compliance of its staff with strict standards of security and confidentiality.
Privacy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agnieszka Bojarczuk
Sales & Marketing Director, North Eastern Europe

Natalia Bochenko
Administration & Marketing Coordinator
[email protected]

Michał Stępniak
Data Privacy Person
[email protected]

[email protected]
If we have given you a SEPA direct debit mandate, please send us a form:
[email protected]